Related by context. All words. (Click for frequent words.) 79 viral load 69 HIV RNA 69 CD4 counts 68 undetectable viral load 67 HCV RNA 67 HBV DNA 67 copies mL 66 CD4 cell 65 copies ml 65 viral suppression 65 virologic failure 65 viremia 63 HAART 63 serum HBV DNA 63 sustained virologic response 63 undetectable viral loads 62 CD4 + cell 61 neutrophil counts 61 lopinavir 61 plasma HCV RNA 61 virologic response 61 platelet counts 61 HBV DNA levels 60 serum HCV RNA 60 indinavir 60 HIV infection 60 raltegravir 60 viraemia 60 rapid virologic response 60 IU mL 59 antiretroviral therapy 59 antibody responses 59 NRTIs 59 ritonavir boosted 59 serum creatinine levels 59 NNRTI resistance 59 virologic 59 hemoglobin concentrations 59 LEXIVA r 58 fosamprenavir 58 recurrent genital herpes 58 adefovir 58 disease progression 58 urate levels 58 nelfinavir 58 CD8 responses 58 serum urate 58 TDF FTC 58 experienced virologic failure 58 antibody titers 58 plasma concentrations 58 coinfected 58 virologically 58 seroconverted 58 virological suppression 58 HbA1c levels 58 undetectable viral 58 HCV infected 58 undetectable HCV RNA 57 CD4 count 57 seroconversion 57 antiretroviral naive 57 virological failure 57 virologic suppression 57 CD4 57 HAART regimen 57 NRTI 57 valacyclovir 57 μmol L 57 NNRTI 57 uninfected 57 atazanavir 57 titers 57 genotypic resistance 57 virological response 57 antiretroviral therapy ART 57 serum uric acid 57 dose ritonavir 57 nanomolar 57 HCV genotype 1 57 serum calcium levels 57 antibody titer 57 HBeAg positive 56 peginterferon 56 sustained virological response 56 log# reduction 56 ABC/3TC 56 potent antiretroviral therapy 56 elvitegravir 56 serum testosterone 56 tipranavir ritonavir 56 CCyR 56 HIV infected 56 protease inhibitor PI 56 HBeAg seroconversion 56 M#V mutation 56 fasting glucose levels 56 K#N 56 CD4 + cells 56 cART 56 ribavirin 56 ribavirin therapy 56 seropositive 56 enfuvirtide 56 paricalcitol 56 serum LDL cholesterol 56 lymphocyte counts 56 log# copies mL 55 virologic responses 55 darunavir 55 ritonavir 55 Viral load 55 saquinavir 55 amprenavir 55 antiretroviral regimen 55 serum calcium 55 serum potassium 55 dose cyclophosphamide 55 blood Phe levels 55 abacavir lamivudine 55 nevirapine Viramune 55 serum urate levels 55 LEXIVA 55 tipranavir 55 HCV replicon 55 antiviral efficacy 55 serum phosphorus 55 platelet reactivity 55 neutralizing antibody 55 SHBG levels 55 serum concentrations 55 NNRTIs 55 pCR 55 lopinavir r 55 CMV infection 55 lamivudine 55 blood glucose concentrations 55 sUA 55 lactate dehydrogenase 55 neutrophil count 55 seropositive patients 55 transgene expression 55 ARV therapy 55 bezafibrate 55 AZT zidovudine Retrovir 55 adiponectin levels 55 pegIFN 55 pegylated interferon 55 serum phosphate 55 undetectable HBV DNA 55 IU ml 55 d4T 55 PSA nadir 55 chlamydial infection 55 prospectively defined 54 darunavir ritonavir 54 tenofovir 54 seropositivity 54 HAART regimens 54 boosted atazanavir 54 seronegative 54 specific antigen PSA 54 baseline HbA1c 54 Hb levels 54 plasma uric acid 54 imatinib therapy 54 protease inhibitors PIs 54 lopinavir ritonavir 54 SIV infection 54 CD4 cells 54 plasma glucose 54 TMC# r 54 serum PSA 54 iPTH 54 serum clusterin levels 54 advanced adenomas 54 PREZISTA r 54 neutralizing antibodies 54 rilpivirine 54 CD# upregulation 54 NRTI resistance 54 antiviral activity 54 corticosteroid dose 54 serum vitamin D 54 pg ml 54 steroid dexamethasone 54 null responders 54 median CD4 54 CC genotype 54 IgA 54 antiretroviral naïve 54 CD4s 54 anti HBs 54 systolic dysfunction 54 mucosal healing 54 clodronate 54 viral titers 54 UGT#A# * 54 Hb A1C 54 BRAF mutation 54 microliter 54 lymphocyte count 54 interferon ribavirin 54 immunized mice 54 hsCRP levels 54 proteinuria 54 chronic HCV 54 ritonavir boosted protease inhibitor 54 viral titer 54 antiviral therapy 54 HIV HCV coinfected 54 biochemical relapse 54 protease inhibitor 53 A1C levels 53 cobicistat 53 CD4 T 53 HCV infection 53 HBeAg negative 53 hemoglobin A1c levels 53 PCA3 scores 53 FTC TDF 53 genital ulcers 53 A1c levels 53 HCV genotype 53 complete cytogenetic response 53 HBsAg 53 CD4 + 53 alanine aminotransferase ALT 53 ritonavir Norvir 53 antihypertensive medications 53 CIN3 53 fasting triglyceride levels 53 CD4 + T 53 seroprevalence 53 efavirenz 53 efavirenz Sustiva 53 low dose ritonavir 53 albumin excretion 53 nonresponders 53 pyrazinamide 53 autoantibody levels 53 hemoglobin levels 53 PSADT 53 peginterferon alfa 2a 53 viral replication 53 plasma viremia 53 IgG antibody 53 nmol liter 53 chronic HCV infection 53 nephrotoxicity 53 ng dL 53 adenoma recurrence 53 atazanavir Reyataz 53 APTIVUS r 53 nmol L 53 hepatitis C virus 53 viral kinetics 53 TPV r 53 plasma triglycerides 53 homocysteine concentrations 53 BARACLUDE ® 53 active antiretroviral therapy 53 ddI 53 atazanavir ritonavir 53 entecavir 53 genital secretions 53 PegIFN RBV 53 pg mL 53 colorectal tumors 53 genital ulcer disease 53 serum ALT 53 hemoglobin concentration 53 log# 53 dose cytarabine 53 trastuzumab Herceptin ® 53 tenofovir DF 53 IL#B 53 cells μL 53 serum phosphorus levels 53 immune responses 53 paraprotein 53 Viral Load 53 heavily pretreated 53 serum lipid levels 53 IGFBP 53 baseline CD4 53 thyroglobulin 53 boosted protease inhibitor 53 dose dexamethasone 53 3TC lamivudine Epivir 53 d4T stavudine Zerit 53 IFN α 53 genotype 1b 52 transcriptase inhibitors NNRTIs 52 CrCl 52 Pegasys ® 52 homocysteine levels 52 mg RDEA# 52 infliximab 52 serum sodium 52 HIV uninfected 52 complete cytogenetic 52 dose cohort 52 Virologic 52 hydroxyvitamin D levels 52 glycosylated hemoglobin HbA1c 52 glycated hemoglobin levels 52 HbA1C 52 EGFR gene 52 OADs 52 parasitaemia 52 baseline LDH 52 CD4 lymphocyte count 52 LDL cholesterol levels 52 platelet aggregation 52 TT genotype 52 adiponectin concentrations 52 transferrin saturation 52 tipranavir r 52 HCV 52 uric acid levels 52 antigen PSA levels 52 tenofovir FTC 52 antiandrogen 52 dapagliflozin plus 52 CatB 52 daunorubicin 52 homozygotes 52 QTcF 52 heterozygotes 52 sulfadoxine pyrimethamine 52 interferon 52 comparator PI r 52 fluvastatin 52 HCV RESPOND 2 52 detectable HCV RNA 52 GSTM1 52 serum potassium levels 52 LPV r 52 HCV viral 52 umol L 52 prostate cancer CaP 52 mg BID 52 hydroxychloroquine 52 peg IFN 52 serum prostate 52 alanine aminotransferase 52 basal cell nevus syndrome 52 serum phosphorous 52 anti retroviral therapy 52 titer 52 Gag polymorphisms 52 endoscopic remission 52 iPrEx study 52 coinfected patients 52 darunavir r 52 EpCAM expression 52 hemoglobin Hb 52 eosinophil count 52 nonnucleoside reverse transcriptase inhibitors 52 bevirimat 52 aspartate aminotransferase 52 NRTI backbone 52 HBeAg 52 interferon IFN 52 adalimumab 52 PASI scores 52 unboosted 52 fructose diet 52 IV bisphosphonates 52 creatinine levels 52 Gag Pol 52 evaluable subjects 52 ACE inhibitor ramipril 52 nucleotide analog 52 NNRTI resistant virus 52 #.#ng/ml 52 Peg IFN 52 tenofovir Viread 52 pyridostigmine 52 HbA1c 52 mL/min/#.# m 2 52 virus HBV 52 IFN beta 52 granulocyte 52 tenofovir emtricitabine 52 EGFR mutations 52 DMARD 52 cells/mm3 52 serum phosphate levels 52 triglyceride levels 52 coinfection 52 RASSF1A 52 HPV# 52 telbivudine 52 serum cholesterol 52 PREZISTA rtv 52 saquinavir ritonavir 52 placebo 52 severe neutropenia 51 replicon 51 hypertensives 51 doxorubicin docetaxel 51 CK # plasma concentrations 51 interferon alfa 51 euthyroid 51 seroprotection 51 thyroxine 51 cervical lesions 51 blood phenylalanine Phe 51 mg dose 51 lumbar spine BMD 51 β blocker 51 #mg dose [002] 51 CLL cells 51 mg kg dose 51 decitabine 51 glucocorticoid 51 thyrotropin levels 51 BCG vaccinated 51 #OHD levels 51 relapsed MM 51 thiazide diuretics 51 genotypes 51 serum PTH 51 hepatic fibrosis 51 LTB4 51 interferon alfa 2a 51 mutated K ras 51 HBeAg negative patients 51 platelet count 51 incontinence episodes 51 annualized relapse 51 moderate renal impairment 51 plasma glucose levels 51 Chlamydia infection 51 HbF 51 co trimoxazole 51 plasma folate 51 progression TTP 51 CMV disease 51 HbA 1c levels 51 DFMO 51 hepatitis C genotype 51 cells mcL 51 lactate dehydrogenase LDH 51 interferon gamma 51 creatinine clearance 51 mycophenolate mofetil 51 LDL C 51 pulmonary exacerbations 51 combination antiretroviral therapy 51 atypical hyperplasia 51 dose regimen 51 mIU L 51 anthracycline containing 51 response CCyR 51 ribavirin RBV 51 zidovudine lamivudine 51 dose cohorts 51 mcg dose 51 endometrial carcinoma 51 β blockers 51 AZT 3TC 51 amoxicillin clavulanate 51 bronchodilation 51 lopinavir ritonavir Kaletra 51 benazepril 51 APTIVUS 51 recurrent UTI 51 efavirenz EFV 51 mIU ml 51 immunocompetent 51 timepoints 51 serodiscordant couples 51 cranial irradiation 51 inhibit replication 51 aminotransferase levels 51 COMBIVIR 51 mRCC 51 interferon alpha 51 Vacc 4x 51 genotypic 51 transfected 51 antihypertensive therapy 51 transaminase levels 51 statistically significant p 51 CsA 51 selenium supplementation 51 HI titers 51 ng ml 51 pentoxifylline 51 lamivudine refractory patients 51 CLA supplementation 51 docetaxel 51 EBV infection 51 herpes infections 51 vicriviroc 51 emtricitabine tenofovir 51 renal toxicity 51 cEVR 51 penetrance 51 aciclovir 51 grade dysplasia 51 FOXP3 51 TMC# [001] 51 Pegasys plus Copegus 51 serum antibody 51 genotype 51 Inhibin B 51 creatinine ratio 51 ibandronate 51 ritonavir boosted lopinavir 51 noncarriers 51 dose colchicine 51 genital herpes infections 51 MS relapses 51 rapid virological response 51 CCL#L# 51 airway responsiveness 51 plus ribavirin 51 dexamethasone Decadron 51 ApoB 51 serum cortisol 51 KRAS mutations 51 nadir CD4 cell 51 aminotransferase ALT 51 ABCB1 51 lopinavir r arm 51 mitoxantrone 51 HER2/neu 50 mg/m2 dose 50 p# activation 50 -#.# log# 50 #mmHg [002] 50 #mg dose [001] 50 azacytidine 50 GBV C 50 mEq L 50 virologic failures 50 MnSOD 50 peripheral blood mononuclear 50 administered subcutaneously 50 ZFN modified cells 50 NPH insulin 50 heterozygous 50 inflammatory biomarkers 50 prevalences 50 #mg QD [001] 50 prior chemotherapy regimens 50 superinfection 50 antiretroviral ARV therapy 50 troponin T 50 median PFS 50 dexrazoxane 50 lamivudine resistant 50 5-FU/LV 50 plasma pharmacokinetics 50 virologic response EVR 50 μg ml 50 undetectable virus HCV 50 Viread Emtriva 50 ertapenem 50 normotensive 50 imatinib 50 chlorambucil 50 beta blocker therapy 50 urinary excretion 50 relapsers 50 STELARA ® 50 variant alleles 50 DAS# [002] 50 GSTT1 50 eGFR 50 anemia hemoglobin 50 thyroid stimulating hormone 50 endogenous EPO 50 HER2 expression 50 vWF 50 telomere lengths 50 sulfasalazine 50 viremic 50 radiographic progression 50 circulating lymphocytes 50 VZV 50 colorectal tumor 50 ascending doses 50 telomerase activity 50 % CI #.#-#.# [003] 50 hepatoma 50 antiretroviral 50 fasting plasma glucose FPG 50 #mmHg [001] 50 serum testosterone levels 50 invasive ductal 50 glycemia 50 Kaplan Meier analysis 50 spontaneous preterm delivery 50 lipid lowering therapy 50 REYATAZ r 50 IgM 50 bosentan 50 Ad5 immunity 50 placebo dexamethasone 50 colorectal neoplasia 50 immune reconstitution 50 initiating antiretroviral therapy 50 potent antiviral 50 serum IGF 50 azathioprine 50 multivariate analyzes 50 unprotected anal sex 50 PREZISTA ritonavir 50 SIV infected 50 prednisone prednisolone 50 WT1 50 cortisol levels 50 dasatinib 50 calcitriol 50 latently infected 50 leukocyte count 50 statistical significance p 50 B7 H3 50 gliclazide 50 HCV genotypes 50 protease inhibitors 50 dose regimens 50 Antiretroviral Therapy 50 anti dsDNA antibodies 50 integrase inhibitor 50 plus methotrexate 50 A1Cs 50 peginterferon alfa 2b 50 initiating HAART 50 elevated LDL cholesterol 50 biochemical recurrence 50 fasting insulin 50 plasma renin activity 50 tuberculin skin testing 50 corticosterone levels 50 evaluable patients 50 tiotropium 50 candesartan cilexetil 50 receiving antiretroviral therapy 50 systolic blood pressures 50 alfa 2a 50 sperm motility 50 liver histology 50 chlorthalidone 50 unprotected anal intercourse 50 PEG IFN 50 suppress viral replication 50 inhibitory concentration 50 intravenous bisphosphonates 50 hemoglobin A1c HbA1c 50 pharmacokinetic interactions 50 univariate analysis 50 overt hypothyroidism 50 blood Phe 50 alpha defensins 50 ug mL 50 stavudine 50 multivariable analysis 50 #ng/ml 50 monoinfected 50 intracranial hemorrhage ICH 50 achieved ACR# 50 Aptivus ® 50 mRNA expression 50 peg interferon 50 teriflunomide 50 timepoint 50 ACTH 50 triglyceride concentrations 50 REYATAZ r arm 50 pulmonary artery pressure 50 sarcosine 50 glomerular filtration rate 50 KRAS mutant tumors 50 severe rotavirus gastroenteritis 50 HIV seroconversion 50 external genital lesions 50 glomerular filtration 50 etravirine 50 oral FTY# 50 Bcl xL 50 triacylglycerol concentrations 50 rhTSH 50 coronary calcification 50 antiretroviral treatment 50 NNAL 50 #mg ATC 50 SCIg 50 dose atorvastatin 50 insulin detemir 50 μg dose 50 cytotoxicity 50 CD8 T cell 50 chronic HBV 50 nucleoside naive 50 bcr abl 50 pegylated interferon alfa 2a 50 K ras mutations 50 Cmax 50 C#Y 50 pathogenic viruses 50 HLA B 49 immunological responses 49 androgen therapy 49 antibody titres 49 inhibitor RG# 49 mL/min/#.# m2 49 ritonavir boosted atazanavir 49 allopurinol 49 CCR5 tropic HIV 49 fetuin 49 IFNg 49 SHBG 49 ISENTRESS 49 lipid levels 49 tumor shrinkage 49 TNF antagonist 49 IFN gamma 49 Prostate Specific Antigen PSA 49 shorter telomere length 49 resected pancreatic cancer 49 receiving VICTRELIS 49 sUA levels 49 intensive statin therapy 49 plasma leptin 49 infliximab therapy 49 hyperphenylalaninemia HPA due 49 receptive anal intercourse 49 piperacillin tazobactam 49 Raltegravir 49 mg QD 49 bilirubin levels 49 HIV 49 TNFα 49 ejection fractions 49 plasma urate 49 valproate 49 GSTP1 49 serum creatinine 49 grade glioma 49 IDX# 49 darunavir Prezista 49 DMARDs 49 dosing frequency 49 oxcarbazepine 49 single dose nevirapine 49 cabazitaxel 49 flutamide 49 serum folate 49 concomitant medications 49 antiviral potency 49 anti leukemic 49 inotropic 49 p = #.# [003] 49 placental malaria 49 homozygous 49 Immunohistochemical analysis 49 posaconazole 49 topotecan 49 serum albumin 49 HBeAg positive patients 49 corticosteroid therapy 49 PBMCs 49 #.#/#.# mm Hg [003] 49 reach statistical significance 49 NT proBNP concentrations 49 achieve sustained virologic 49 losartan 49 grade gliomas 49 glycosylated hemoglobin 49 immunogenicity 49 myeloperoxidase 49 peginterferon alpha 2a 49 Ritonavir 49 % CI #.#-#.# [007] 49 achieved sustained virological 49 diabetic mice 49 URTI 49 estimated glomerular filtration 49 HIV seronegative 49 atherogenic lipids 49 left ventricular ejection 49 virulence genes 49 HBV vaccine 49 monotherapy 49 HOMA IR 49 mediated immunity 49 liver transplant recipients 49 nocturnal hypoglycaemia 49 solifenacin 49 suppressive therapy 49 mm ³ 49 HIV prevalence 49 FEV1 49 peginterferon alfa 49 ug dose 49 rifabutin 49 pT3 49 fasting plasma glucose 49 cells uL 49 microg 49 IGFBP 3 49 tHcy 49 poor metabolizers 49 HPV-#/# 49 anti Xa 49 glycosylated hemoglobin levels 49 carvedilol 49 Epivir 49 K#R [002] 49 Combination therapy 49 YKL 49 S/GSK# 49 diabetic rats 49 Sustained Virologic Response 49 systemic toxicity 49 achieved statistical significance 49 valproic acid 49 CR nPR 49 androgen deprivation 49 IELT 49 treatment naļve 49 sotalol 49 transcriptase inhibitors 49 colorectal carcinoma 49 induced sputum 49 elevated ALT 49 lamivudine zidovudine 49 airway hyper responsiveness 49 atazanavir sulfate 49 liver biopsies 49 bFGF 49 NAbs 49 MMSE score 49 dosing cohorts 49 mcg mL 49 immunodeficient 49 S. aureus isolates 49 hypophosphatemia 49 imetelstat 49 gefitinib 49 S#A# [002] 49 LTBI 49 hematologic toxicity 49 thyrotropin 49 serum homocysteine 49 blood glucose levels 49 leflunomide 49 transcriptase inhibitor NNRTI 49 nucleoside analogues 49 HBV 49 mcg BID 49 rituximab 49 advanced adenoma 49 q8h 49 breast carcinoma 49 neutralizing antibody responses 49 lipid lowering therapies 49 CDAI 49 lymphocytosis 49 -#.# log# copies mL 49 nucleoside reverse transcriptase inhibitor 49 active comparator 49 octreotide LAR 49 osteopontin 49 3TC 49 D2 receptors 49 stone formers 49 cotinine levels 49 advanced neoplasia 49 trimethoprim sulfamethoxazole 49 lung function 49 caspofungin 49 mitoxantrone chemotherapy 49 cTnT 49 transaminase elevations 49 Cortisol levels 49 proguanil 49 acute GvHD 49 density lipoprotein cholesterol 49 creatine kinase 49 dose Iluvien 49 Darunavir 49 anti retroviral therapy HAART 49 CD8 T 49 rs# [001] 49 Gleevec resistant 49 mapatumumab 49 serum BDNF 49 triiodothyronine 49 inhaled steroid 49 histologically confirmed 49 mcg doses 49 tubulin polymerization 49 4CMenB 49 intact parathyroid hormone 49 DLCO 49 nicardipine 49 antiretroviral regimens 49 PEG Interferon alfa 49 valsartan amlodipine 49 Gilead Viread 49 Neisseria gonorrhoeae 49 antiretroviral therapies 49 ng dl 49 chloride secretion 49 Therapy HAART 49 nilotinib 49 evaluating tivozanib 49 pegylated liposomal doxorubicin 49 MELD scores 49 rhGH 49 colorectal adenoma 49 chemotherapy regimens 49 BRCA mutation 49 H pylori 49 reinfection 49 aminotransferases 49 serum bicarbonate 49 TNFalpha 48 leukopenia 48 splenectomized patients 48 baseline A1C 48 mg ustekinumab 48 stavudine d4T 48 mammographic density 48 promoter methylation 48 morphometric vertebral fractures 48 protein excretion 48 Hepsera 48 HCV antibody 48 hyperoxia 48 endostatin 48 JAK2 V#F 48 mIU mL 48 elevated CRP 48 hemagglutination inhibition HAI 48 serum aminotransferase levels 48 rheumatoid factor 48 tertile 48 cystatin C 48 HBV infection 48 distant metastases 48 locoregional disease 48 azacitidine 48 #mg/m# [002] 48 imipenem 48 MIF gene 48 inflammatory markers 48 IFN alpha 48 plasma glucose concentrations 48 infectivity 48 PCa 48 cardiovascular mortality 48 #mg BID [002] 48 evaluable 48 urinary calcium 48 urinary iodine 48 R5 tropic 48 pegylated interferon alfa 48 zidovudine 48 remission CR 48 genital ulcer 48 unprotected vaginal 48 dexamethasone 48 Retroviruses 48 neoadjuvant chemotherapy 48 antiretroviral drugs 48 lymphopenia 48 μg L 48 Sustiva efavirenz 48 tumor regression 48 Index CDAI 48 systemic bioavailability 48 pimozide 48 virologic breakthrough 48 serum CRP 48 nitazoxanide 48 hypertensive patients 48 calculated creatinine clearance 48 variant allele 48 T2DM 48 cytogenetic response 48 lamivudine 3TC 48 contrast induced nephropathy 48 adalimumab Humira 48 concentration Cmax 48 immunosuppressive agents 48 CANCIDAS 48 etoposide 48 interferon alfa 2b 48 cortisol concentrations 48 grade cervical intraepithelial 48 cytarabine daunorubicin